Total Funding
65
78
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
35722
Ranok Therapeutics is a biotechnology company that is pioneering an innovative targeted protein degradation technology.
- Kevin P. Foley`: Co-founder & Chief Scientific Officer
- Weiwen Ying: Founder and CEO
About the Company
Ranok Therapeutics is a biotechnology company that is developing a novel targeted protein degradation technology to aid in the discovery and development of novel therapeutics. Ranok's TPD technology engages various underlying biological processes and outperforms competing TPD approaches. Ranok's pipeline contains both well-validated and
novel drug targets involved in cancer and other diseases with significant unmet medical needs. Ranok is dedicated to developing the next generation of cancer therapies that are both safer and more effective.
